Sage Therapeutics (SAGE) shares surged nearly 38% in recent Monday premarket activity after it said late Friday Biogen (BIIB) had submitted an unsolicited, nonbinding proposal to acquire all outstanding shares of the company not already owned for $7.22 a share.
Intra-Cellular Therapies (ITCI) stock rose nearly 35% after it signed a definitive deal to be acquired by Johnson & Johnson (JNJ) for $132 per share in cash for a total equity value of about $14.6 billion, the companies said Monday.
Pediatrix Medical Group (MD) shares rose nearly 16% after saying it appointed Executive Chair Mark Ordan as chief executive officer, effective immediately.
Molecular Partners (MOLN) stock jumped 22%, after it expanded its strategic partnership with Orano Med to include the development of an additional six targeted alpha radio-therapies for cancer, the companies said Sunday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。